Literature DB >> 29317431

Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies.

Gaelle Auguste1, Priyatansh Gurha1, Raffaella Lombardi1, Cristian Coarfa1, James T Willerson1, Ali J Marian2.   

Abstract

RATIONALE: Mutations in the LMNA gene, encoding nuclear inner membrane protein lamin A/C, cause distinct phenotypes, collectively referred to as laminopathies. Heart failure, conduction defects, and arrhythmias are the common causes of death in laminopathies.
OBJECTIVE: The objective of this study was to identify and therapeutically target the responsible mechanism(s) for cardiac phenotype in laminopathies. METHODS AND
RESULTS: Whole-heart RNA sequencing was performed before the onset of cardiac dysfunction in the Lmna-/- and matched control mice. Differentially expressed transcripts and their upstream regulators were identified, validated, and targeted by adeno-associated virus serotype 9-short hairpin RNA constructs. A total of 576 transcripts were upregulated and 233 were downregulated in the Lmna-/- mouse hearts (q<0.05). Forkhead box O (FOXO) transcription factors (TFs) were the most activated while E2 factors were the most suppressed transcriptional regulators. Transcript levels of FOXO targets were also upregulated in the isolated Lmna-/- cardiac myocytes and in the myocardium of human heart failure patients. Nuclear localization of FOXO1 and 3 was increased, whereas phosphorylated (inactive) FOXO1 and 3 levels were reduced in the Lmna-/- hearts. Gene set enrichment analysis and gene ontology showed activation of apoptosis and inflammation and suppression of cell cycle, adipogenesis, and oxidative phosphorylation in the Lmna-/- hearts. Adeno-associated virus serotype 9-short hairpin RNA-mediated suppression of FOXO TFs rescued selected molecular signatures, improved apoptosis, and prolonged survival by ≈2-fold.
CONCLUSIONS: FOXO TFs are activated and contribute to the pathogenesis of cardiac phenotype in laminopathies. Suppression of the FOXO TFs in cardiac myocytes partially rescues the phenotype and prolongs survival. The findings identify FOXO TFs as potential therapeutic targets for cardiac phenotype in laminopathies.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  forkhead transcription factors; gene ontology; genetic therapy; transcription factors; transcriptome

Mesh:

Substances:

Year:  2018        PMID: 29317431      PMCID: PMC5834384          DOI: 10.1161/CIRCRESAHA.117.312052

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  62 in total

1.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.

Authors:  Matthew R G Taylor; Pamela R Fain; Gianfranco Sinagra; Misi L Robinson; Alastair D Robertson; Elisa Carniel; Andrea Di Lenarda; Teresa J Bohlmeyer; Debra A Ferguson; Gary L Brodsky; Mark M Boucek; Jean Lascor; Andrew C Moss; Wai Lun P Li; Gary L Stetler; Francesco Muntoni; Michael R Bristow; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

2.  Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Eduardo Garcia-Gras; Raffaella Lombardi; Michael J Giocondo; James T Willerson; Michael D Schneider; Dirar S Khoury; Ali J Marian
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

3.  Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals.

Authors:  Xiaohui Xie; Jun Lu; E J Kulbokas; Todd R Golub; Vamsi Mootha; Kerstin Lindblad-Toh; Eric S Lander; Manolis Kellis
Journal:  Nature       Date:  2005-02-27       Impact factor: 49.962

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection.

Authors:  Lin Yang; Jiangang Jiang; Lauren M Drouin; Mavis Agbandje-McKenna; Chunlian Chen; Chunping Qiao; Dongqiuye Pu; Xiaoyun Hu; Da-Zhi Wang; Juan Li; Xiao Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

6.  Cardiac Fibro-Adipocyte Progenitors Express Desmosome Proteins and Preferentially Differentiate to Adipocytes Upon Deletion of the Desmoplakin Gene.

Authors:  Raffaella Lombardi; Suet Nee Chen; Alessandra Ruggiero; Priyatansh Gurha; Grazyna Z Czernuszewicz; James T Willerson; Ali J Marian
Journal:  Circ Res       Date:  2016-04-27       Impact factor: 17.367

7.  Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease.

Authors:  Darin J Falk; Cathryn S Mah; Meghan S Soustek; Kun-Ze Lee; Mai K Elmallah; Denise A Cloutier; David D Fuller; Barry J Byrne
Journal:  Mol Ther       Date:  2013-06-04       Impact factor: 11.454

Review 8.  The FoxO code.

Authors:  D R Calnan; A Brunet
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

9.  Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes.

Authors:  A J Marian; Q T Yu; D L Mann; F L Graham; R Roberts
Journal:  Circ Res       Date:  1995-07       Impact factor: 17.367

Review 10.  Current insights into LMNA cardiomyopathies: Existing models and missing LINCs.

Authors:  Daniel Brayson; Catherine M Shanahan
Journal:  Nucleus       Date:  2017-01-02       Impact factor: 4.197

View more
  22 in total

1.  Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1.

Authors:  Peng Xia; Jingrui Chen; Yuening Liu; Maya Fletcher; Brian C Jensen; Zhaokang Cheng
Journal:  J Biol Chem       Date:  2020-02-19       Impact factor: 5.157

2.  DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.

Authors:  Suet Nee Chen; Raffaella Lombardi; Jennifer Karmouch; Ju-Yun Tsai; Grace Czernuszewicz; Matthew R G Taylor; Luisa Mestroni; Cristian Coarfa; Priyatansh Gurha; Ali J Marian
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

3.  Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.

Authors:  Sirisha M Cheedipudi; Scot J Matkovich; Cristian Coarfa; Xin Hu; Matthew J Robertson; Mary Sweet; Matthew Taylor; Luisa Mestroni; Joseph Cleveland; James T Willerson; Priyatansh Gurha; Ali J Marian
Journal:  Circ Res       Date:  2019-04-12       Impact factor: 17.367

4.  Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.

Authors:  Sirisha M Cheedipudi; Jinzhu Hu; Siyang Fan; Ping Yuan; Jennifer Karmouch; Grace Czernuszewicz; Matthew J Robertson; Cristian Coarfa; Kui Hong; Yan Yao; Hanna Campbell; Xander Wehrens; Priyatansh Gurha; Ali J Marian
Journal:  Cardiovasc Res       Date:  2020-05-01       Impact factor: 10.787

5.  BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C-deficient mice.

Authors:  Gaelle Auguste; Leila Rouhi; Scot J Matkovich; Cristian Coarfa; Matthew J Robertson; Grazyna Czernuszewicz; Priyatansh Gurha; Ali J Marian
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

6.  The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer.

Authors:  Lucia Cicchillitti; Rahma Said; Nouha Setti Boubaker; Aymone Gurtner; Haroun Ayed; Ahlem Blel; Omar Karray; Mohamed Ali Essid; Maroua Gharbi; Abderrazek Bouzouita; Soumaya Rammeh Rommeni; Mohamed Chebil; Giulia Piaggio; Slah Ouerhani
Journal:  Mol Biol Rep       Date:  2019-06-18       Impact factor: 2.316

7.  Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.

Authors:  Leila Rouhi; Sirisha M Cheedipudi; Suet Nee Chen; Siyang Fan; Raffaella Lombardi; Xiaofan Chen; Cristian Coarfa; Matthew J Robertson; Priyatansh Gurha; Ali J Marian
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 13.081

8.  The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.

Authors:  Leila Rouhi; Siyang Fan; Sirisha M Cheedipudi; Aitana Braza-Boïls; Maria Sabater Molina; Yan Yao; Matthew J Robertson; Cristian Coarfa; Juan R Gimeno; Pilar Molina; Priyatansh Gurha; Esther Zorio; Ali J Marian
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

9.  Single-Cell RNA Sequencing Uncovers Paracrine Functions of the Epicardial-Derived Cells in Arrhythmogenic Cardiomyopathy.

Authors:  Ping Yuan; Sirisha M Cheedipudi; Leila Rouhi; Siyang Fan; Lukas Simon; Zhongming Zhao; Kui Hong; Priyatansh Gurha; Ali J Marian
Journal:  Circulation       Date:  2021-03-17       Impact factor: 39.918

Review 10.  An Omics View of Emery-Dreifuss Muscular Dystrophy.

Authors:  Nicolas Vignier; Antoine Muchir
Journal:  J Pers Med       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.